Home Life Sciences Transgenic mouse brains for the evaluation and quality control of BSE tests
Article
Licensed
Unlicensed Requires Authentication

Transgenic mouse brains for the evaluation and quality control of BSE tests

  • Wolfgang J. Philipp , Darlene Groth , Kurt Giles , Pavel Vodrazka , Heinz Schimmel , Muriel Feyssaguet , Reet Toomik , Pascal Schacher , Awad A. Osman , Ingolf Lachmann , Angus Wear , Jean-Noel Arsac and Stanley B. Prusiner
Published/Copyright: March 5, 2007
Biological Chemistry
From the journal Volume 388 Issue 3

Abstract

Rapid BSE tests are widely used diagnostics in veterinary medicine and more than 11 million tests are applied worldwide. The evaluation of new rapid BSE tests and the quality assurance of approved BSE tests pose a challenge owing to the natural scarcity of BSE-infected bovine brainstems and regional variations in prion titer. Transgenic mice expressing bovine prion protein (Tg4092) offer an alternative approach to these problems. To determine whether BSE-infected Tg4092 mouse brains could serve as a general standard for rapid BSE tests, we inoculated Tg4092 mice intracerebrally with BSE prions, harvested brains at defined time points post-infection and analyzed cerebral hemispheres with several approved rapid BSE tests. The results show that de novo formation of the disease-causing prion protein isoform, PrPSc, can be monitored during the course of infection. We demonstrate that BSE-infected Tg4092 mouse brains provide a renewable and controllable source of reference samples and suggest that such samples can generally be used for the evaluation and quality control of rapid BSE tests.

:

Corresponding author

References

Asante, E.A., Linehan, J.M., Desbruslais, M., Joiner, S., Gowland, I., Wood, A.L., Welch, J., Hill, A.F., Lloyd, S.E., Wadsworth, J.D., and Collinge, J. (2002). BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein. EMBO J.21, 6358–6366.10.1093/emboj/cdf653Search in Google Scholar

Carlson, G.A., Ebeling, C., Yang, S.L., Telling, G., Torchia, M., Groth, D., Westaway, D., DeArmond, S.J., and Prusiner, S.B. (1994). Prion isolate specified allotypic interactions between the cellular and scrapie prion proteins in congenic and transgenic mice. Proc. Natl. Acad. Sci. USA91, 5690–5694.10.1073/pnas.91.12.5690Search in Google Scholar

European Communities (2001). Regulation No 999/2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies. Off. J. Eur. Communities L147/1, http://europa.eu.int/scadplus/leg/en/ lvb/f83001.htm.Search in Google Scholar

Korth, C., Kaneko, K., Groth, D., Heye, N., Telling, G., Mastrianni, J., Parchi, P., Gambetti, P., Will, R., Ironside, J., et al. (2003). Abbreviated incubation times for human prions in mice expressing a chimeric mouse-human prion protein transgene. Proc. Natl. Acad. Sci. USA100, 4784–4789.10.1073/pnas.2627989100Search in Google Scholar

Philipp, W. and Vodrazka, P. (2004). The field trial of seven new rapid post mortem tests for the diagnosis of bovine spongiform encephalopathy in bovines. http://www.irmm.jrc.be/ html/activities/TSE_testing/GlobalreportphaseII.pdf.Search in Google Scholar

Philipp, W., van Iwaarden, P., Goll, M., Kollmorgen, N., Schimmel, H., and Vodrazka, P. (2004). The evaluation of 10 rapid post mortem tests for the diagnosis of bovine spongiform encephalopathy in bovines. www.irmm.jrc.be/htlm/activities/ TSE_testing/PhaseIBSEtestevaluation.pdf.Search in Google Scholar

Prusiner, S.B., Safar, J.G., and DeArmond, S.J. (2004). Bioassays of prions. In: Prion Biology and Diseases, 2nd edition, S.B. Prusiner, ed. (Cold Spring Harbor, NY, USA: Cold Spring Harbor Laboratory Press), pp. 143–186.Search in Google Scholar

Safar, J.G., Scott, M., Monaghan, J., Deering, C., Didorenko, S., Vergara, J., Ball, H., Legname, G., Leclerc, E., Solforosi, L., et al. (2002). Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice. Nat. Biotechnol.20, 1147–1150.10.1038/nbt748Search in Google Scholar

Scott, M., Foster, D., Mirenda, C., Serban, D., Coufal, F., Walchli, M., Torchia, M., Groth, D., Carlson, G., DeArmond, S.J., et al. (1989). Transgenic mice expressing hamster prion protein produce species-specific scrapie infectivity and amyloid plaques. Cell59, 847–857.10.1016/0092-8674(89)90608-9Search in Google Scholar

Scott, M.R., Safar, J., Telling, G., Nguyen, O., Groth, D., Torchia, M., Koehler, R., Tremblay, P., Walther, D., Cohen, F.E., et al. (1997). Identification of a prion protein epitope modulating transmission of bovine spongiform encephalopathy prions to transgenic mice. Proc. Natl. Acad. Sci. USA94, 14279–14284.10.1073/pnas.94.26.14279Search in Google Scholar

Scott, M.R., Will, R., Ironside, J., Nguyen, H.O., Tremblay, P., DeArmond, S.J., and Prusiner, S.B. (1999). Compelling transgenetic evidence for transmission of bovine spongiform encephalopathy prions to humans. Proc. Natl. Acad. Sci. USA96, 15137–15142.10.1073/pnas.96.26.15137Search in Google Scholar

Scott, M.R., Peretz, D., Nguyen, H.-O.B., DeArmond, S.J., and Prusiner, S.B. (2005). Transmission barriers for bovine, ovine, and human prions in transgenic mice. J. Virol.79, 5259–5271.10.1128/JVI.79.9.5259-5271.2005Search in Google Scholar

Supattapone S., Bosque, P., Muramoto, T., Wille, H., Aagaard, C., Peretz, D., Nguyen, H.O., Heinrich, C., Torchia, M., Safar, J., et al. (1999). Prion protein of 106 residues creates an artificial transmission barrier for prion replication in transgenic mice. Cell96, 869–878.10.1016/S0092-8674(00)80596-6Search in Google Scholar

Published Online: 2007-03-05
Published in Print: 2007-03-01

©2007 by Walter de Gruyter Berlin New York

Articles in the same Issue

  1. Supplementary material to the paper “Evolutionary selection pressure and family relationships among connexin genes”
  2. Evolutionary selection pressure and family relationships among connexin genes
  3. Characterization of the large subunit of EcoHK31I methyltransferase by structural modeling and mutagenesis
  4. Purification, characterization, and molecular gene cloning of an antifungal protein from Ginkgo biloba seeds
  5. Maximal Ca2+i stimulation of cardiac Na+/Ca2+ exchange requires simultaneous alkalinization and binding of PtdIns-4,5-P2 to the exchanger
  6. A highly conserved protein secreted by the prostate cancer cell line PC-3 is expressed in benign and malignant prostate tissue
  7. Properties and partial purification of sialate-O-acetyltransferase from bovine submandibular glands
  8. Raft association and lipid droplet targeting of flotillins are independent of caveolin
  9. On the presence of C2-ceramide in mammalian tissues: possible relationship to etherphospholipids and phosphorylation by ceramide kinase
  10. Specific inhibition of interleukin-13 activity by a recombinant human single-chain immunoglobulin domain directed against the IL-13 receptor α1 chain
  11. Effects of disease-modifying anti-rheumatic drugs (DMARDs) on the activities of rheumatoid arthritis-associated cathepsins K and S
  12. Compartmentalised expression of meprin in small intestinal mucosa: enhanced expression in lamina propria in coeliac disease
  13. Human dipeptidyl peptidase III acts as a post-proline-cleaving enzyme on endomorphins
  14. Transgenic mouse brains for the evaluation and quality control of BSE tests
Downloaded on 19.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/BC.2007.040/html
Scroll to top button